3 weeks Pfizer to combine off-patent drug business with Mylan ABS-CBN |Biz
Pfizer announced Monday it will merge its off-patent drug business with generic drugmaker Mylan to create a global leader in low-cost treatment, a business that faces significant political pressure in the US. ... more